Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling

Journal:

European Heart Journal

Published:

2026-06-29

DOI:

10.1093/eurheartj/ehag487

Affiliations:

8

Authors:

17

Go to article

Institutions	Authors	Share
Pfizer, United States of America (USA)	5.000000	0.29
University of Pennsylvania (Penn), United States of America (USA)	3.166667	0.19
Abramson Cancer Center, Penn, United States of America (USA)	2.833333	0.17
City of Hope Comprehensive Cancer Center, United States of America (USA)	2.000000	0.12
Sapient Bioanalytics, LLC., United States of America (USA)	2.000000	0.12
University of Ottawa Heart Institute, Canada	2.000000	0.12